Cited 0 times in
Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 전성하 | - |
dc.contributor.author | 정현철 | - |
dc.contributor.author | 정희철 | - |
dc.contributor.author | 천재희 | - |
dc.contributor.author | 최혜진 | - |
dc.contributor.author | 금기창 | - |
dc.contributor.author | 김남규 | - |
dc.contributor.author | 노재경 | - |
dc.contributor.author | 라선영 | - |
dc.contributor.author | 백승혁 | - |
dc.contributor.author | 신상준 | - |
dc.contributor.author | 안중배 | - |
dc.date.accessioned | 2015-05-19T16:24:59Z | - |
dc.date.available | 2015-05-19T16:24:59Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0167-8140 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/106265 | - |
dc.description.abstract | S-1 is a novel, oral fluoropyrimidine and a known radiosensitizer. We conducted a phase I trial to establish a schedule of S-1/irinotecan with standard pelvic radiotherapy as a preoperative treatment of locally advanced rectal cancer. Our findings suggest that this new combination is feasible and well tolerable | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 361~366 | - |
dc.relation.isPartOf | RADIOTHERAPY AND ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adenocarcinoma/drug therapy* | - |
dc.subject.MESH | Adenocarcinoma/radiotherapy* | - |
dc.subject.MESH | Adenocarcinoma/surgery | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Antineoplastic Agents, Phytogenic/administration & dosage | - |
dc.subject.MESH | Antineoplastic Combined Chemotherapy Protocols/therapeutic use* | - |
dc.subject.MESH | Camptothecin/administration & dosage | - |
dc.subject.MESH | Camptothecin/analogs & derivatives | - |
dc.subject.MESH | Combined Modality Therapy | - |
dc.subject.MESH | Drug Combinations | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Maximum Tolerated Dose | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neoadjuvant Therapy | - |
dc.subject.MESH | Oxonic Acid/administration & dosage* | - |
dc.subject.MESH | Oxonic Acid/adverse effects | - |
dc.subject.MESH | Radiation-Sensitizing Agents/adverse effects | - |
dc.subject.MESH | Radiation-Sensitizing Agents/therapeutic use* | - |
dc.subject.MESH | Radiotherapy Dosage | - |
dc.subject.MESH | Radiotherapy, High-Energy | - |
dc.subject.MESH | Rectal Neoplasms/drug therapy* | - |
dc.subject.MESH | Rectal Neoplasms/radiotherapy* | - |
dc.subject.MESH | Rectal Neoplasms/surgery | - |
dc.subject.MESH | Tegafur/administration & dosage* | - |
dc.subject.MESH | Tegafur/adverse effects | - |
dc.title | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Hye Jin Choi | - |
dc.contributor.googleauthor | Nam-Kyu Kim | - |
dc.contributor.googleauthor | Ki Chang Keum | - |
dc.contributor.googleauthor | Seong Ha Cheon | - |
dc.contributor.googleauthor | Sang Jun Shin | - |
dc.contributor.googleauthor | Seung Hyuk Baik | - |
dc.contributor.googleauthor | Jae Hee Choen | - |
dc.contributor.googleauthor | Sun Young Rha | - |
dc.contributor.googleauthor | Jae Kyung Roh | - |
dc.contributor.googleauthor | Hei-Cheul Jeung | - |
dc.contributor.googleauthor | Hyun Cheol Chung | - |
dc.contributor.googleauthor | Joong Bae Ahn | - |
dc.identifier.doi | 10.1016/j.radonc.2008.04.001 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A03520 | - |
dc.contributor.localId | A03773 | - |
dc.contributor.localId | A04219 | - |
dc.contributor.localId | A00272 | - |
dc.contributor.localId | A00353 | - |
dc.contributor.localId | A01290 | - |
dc.contributor.localId | A01827 | - |
dc.contributor.localId | A02105 | - |
dc.contributor.localId | A02262 | - |
dc.contributor.localId | A03794 | - |
dc.contributor.localId | A01316 | - |
dc.contributor.localId | A04030 | - |
dc.relation.journalcode | J02597 | - |
dc.identifier.eissn | 1879-0887 | - |
dc.identifier.pmid | 18439695 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0167814008001953 | - |
dc.subject.keyword | S-1 | - |
dc.subject.keyword | Irinotecan | - |
dc.subject.keyword | Neoadjuvant | - |
dc.subject.keyword | Rectal cancer | - |
dc.contributor.alternativeName | Cheon, Seong Ha | - |
dc.contributor.alternativeName | Chung, Hyun Cheol | - |
dc.contributor.alternativeName | Jeung, Hei Cheul | - |
dc.contributor.alternativeName | Cheon, Jae Hee | - |
dc.contributor.alternativeName | Choi, Hye Jin | - |
dc.contributor.alternativeName | Keum, Ki Chang | - |
dc.contributor.alternativeName | Kim, Nam Kyu | - |
dc.contributor.alternativeName | Roh, Jae Kyung | - |
dc.contributor.alternativeName | Rha, Sun Young | - |
dc.contributor.alternativeName | Baik, Seung Hyuk | - |
dc.contributor.alternativeName | Shin, Sang Joon | - |
dc.contributor.alternativeName | Ahn, Joong Bae | - |
dc.contributor.affiliatedAuthor | Cheon, Seong Ha | - |
dc.contributor.affiliatedAuthor | Chung, Hyun Cheol | - |
dc.contributor.affiliatedAuthor | Choi, Hye Jin | - |
dc.contributor.affiliatedAuthor | Keum, Ki Chang | - |
dc.contributor.affiliatedAuthor | Kim, Nam Kyu | - |
dc.contributor.affiliatedAuthor | Roh, Jae Kyung | - |
dc.contributor.affiliatedAuthor | Baik, Seung Hyuk | - |
dc.contributor.affiliatedAuthor | Shin, Sang Joon | - |
dc.contributor.affiliatedAuthor | Ahn, Joong Bae | - |
dc.contributor.affiliatedAuthor | Jeung, Hei Cheul | - |
dc.contributor.affiliatedAuthor | Rha, Sun Young | - |
dc.contributor.affiliatedAuthor | Cheon, Jae Hee | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 87 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 361 | - |
dc.citation.endPage | 366 | - |
dc.identifier.bibliographicCitation | RADIOTHERAPY AND ONCOLOGY, Vol.87(3) : 361-366, 2008 | - |
dc.identifier.rimsid | 56319 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.